K-gen Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 7
Rang # Quantité totale PI 221 309
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 195 655

Brevets

Marques

4 0
2 0
1 0
0
 
Dernier brevet 2024 - Diterpenoid compounds that act o...
Premier brevet 2016 - Methods of cancer treatment

Derniers inventions, produits et services

2023 Invention Use of protein kinase c (pkc) activating compounds as an adjuvant. This present disclosure relate...
2022 Invention Diterpenoid compounds that act on protein kinase c (pkc). This present disclosure relates to a m...
Invention Diterpenoid compounds that act on protein kinase c (pkc). This present disclosure relates to a me...
2020 Invention Diterpenoid compounds that act on protein kinase c (pkc). This present disclosure relates to pro...
Invention Diterpenoid compounds that act on protein kinase c (pkc). This present disclosure relates to prot...
2017 Invention Methods of cancer treatment. This present disclosure is directed to a method of treating a subjec...
2016 Invention Methods of cancer treatment. This present disclosure is directed to a method of selecting a canc...